FTIOP
LGND icon

Fiduciary Trust International of Pennsylvania’s Ligand Pharmaceuticals LGND Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,226
Closed -$210K – 328
2018
Q3 		$210K Buy
+1,226
New +$185K 0.01% 337

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's LGND Position: Q4 2018 in Review

Fiduciary Trust International of Pennsylvania sold out of Ligand Pharmaceuticals (LGND) in Q4 2018, closing a stake of 1,226 shares — an estimated $210K sold.

Fiduciary Trust International of Pennsylvania first reported a position in LGND in Q3 2018 and held it in 1 quarter. The position peaked at $210K in Q3 2018. 362 funds tracked by Wall St. Rank hold LGND as of Q4 2018.

  • Fiduciary Trust International of Pennsylvania reported no remaining Ligand Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Fiduciary Trust International of Pennsylvania sold 1,226 Ligand Pharmaceuticals shares in Q4 2018, an estimated $210K.
  • Fiduciary Trust International of Pennsylvania first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 1 quarter.
  • Fiduciary Trust International of Pennsylvania's Ligand Pharmaceuticals position peaked at $210K in Q3 2018.
  • 362 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2018.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q4 2018, filed 14 Jan 2019.